MAP2K7 and neoplasm: Importantly, combining the autophagy inhibitor hydroxychloroquine (HCQ) together with the MEK inhibitor Trametinib elicited a synergistic anti-proliferative effect in KL mouse lung tumor-derived cell lines (TDCLs), and led to tumor regression in vivo.